Form 13-F position report

INSMED INC

Reported by Long Focus Capital Management LLC

INSM CUSIP 457669307 Manager CIK 0001602716

Reported 528,000 shares, unchanged from the prior quarter.

Reported value 7.1%; share count 0.0% vs. the prior quarter.

Unchanged
% of reported 13F value 1.69% This manager · Q3 2026
Shares 528,000 Quarter-end amount reported
Reported value $60,265,920 Fair value at quarter end
Consecutive quarters held 20 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 2179000
2022-03-31 3760000
2022-06-30 4930000
2022-09-30 5816000
2022-12-31 6493500
2023-03-31 6166115
2023-06-30 7841794
2023-09-30 9384137
2023-12-31 11517403
2024-03-31 11710637
2024-06-30 49640300
2024-09-30 45909700
2024-12-31 44931232
2025-03-31 48123732
2025-06-30 52352928
2025-09-30 48675380
2025-12-31 21755000
2026-03-31 23710400
2026-06-30 56295360
2026-09-30 60265920

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for INSMED INC held by Long Focus Capital Management LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Unchanged 528,000 0 (0.0%) 1.69% $60,265,920 2026-11-16
Q2 2026 Added 528,000 +383,000 (264.1%) 1.44% $56,295,360 2026-08-14
Q1 2026 Added 145,000 +20,000 (16.0%) 0.62% $23,710,400 2026-05-15
Q4 2025 Reduced 125,000 -213,000 (-63.0%) 0.57% $21,755,000 2026-02-17
Q3 2025 Reduced 338,000 -182,200 (-35.0%) 1.61% $48,675,380 2025-11-14
Q2 2025 Reduced 520,200 -110,600 (-17.5%) 1.98% $52,352,928 2025-08-14
Q1 2025 Reduced 630,800 -20,000 (-3.1%) 1.61% $48,123,732 2025-05-15
Q4 2024 Added 650,800 +21,900 (3.5%) 1.46% $44,931,232 2025-02-14
Q3 2024 Reduced 628,900 -112,000 (-15.1%) 1.61% $45,909,700 2024-11-13
Q2 2024 Added 740,900 +309,251 (71.6%) 1.9% $49,640,300 2024-08-14
Q1 2024 Added 431,649 +60,000 (16.1%) 0.6% $11,710,637 2024-05-14
Q4 2023 Unchanged 371,649 0 (0.0%) 0.38% $11,517,403 2024-02-14
Q3 2023 Unchanged 371,649 0 (0.0%) 0.34% $9,384,137 2023-11-14
Q2 2023 Added 371,649 +10,000 (2.8%) 0.36% $7,841,794 2023-08-14
Q1 2023 Added 361,649 +36,649 (11.3%) 0.35% $6,166,115 2023-05-12
Q4 2022 Added 325,000 +55,000 (20.4%) 0.45% $6,493,500 2023-02-13
Q3 2022 Added 270,000 +20,000 (8.0%) 0.57% $5,816,000 2022-11-14
Q2 2022 Added 250,000 +90,000 (56.3%) 0.52% $4,930,000 2022-08-12
Q1 2022 Added 160,000 +80,000 (100.0%) 0.48% $3,760,000 2022-05-13
Q4 2021 New 80,000 +80,000 (0.0%) 0.29% $2,179,000 2022-02-14

Who else reported the position

792 managers reported INSMED INC for Q3 2026.

Managers reporting INSMED INC in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Added 15,908,581 +100,597 0.03% $1,815,805,378 9 qtrs
FMR LLC Reduced 15,518,135 -625,448 0.08% $1,771,240,012 54 qtrs
VANGUARD PORTFOLIO MANAGEMENT LLC Added 10,529,985 +122,023 0.05% $1,201,892,488 3 qtrs
VANGUARD CAPITAL MANAGEMENT LLC Added 9,833,444 +42,579 0.02% $1,122,389,298 3 qtrs
Capital International Investors Added 9,352,633 +1,114,509 0.22% $1,067,518,928 11 qtrs
BAKER BROS ADVISORS LP Unchanged 8,796,111 0 4.77% $1,003,988,110 54 qtrs
JPMorgan Chase & Co Reduced 8,243,537 -2,184,633 0.05% $953,200,480 54 qtrs
Orbis Allan Gray Ltd Added 6,733,982 +657,495 2.56% $768,616,705 6 qtrs
AMERIPRISE FINANCIAL INC Added 6,251,016 +71,445 0.14% $713,493,108 54 qtrs
STATE STREET CORPORATION Added 6,162,413 +110,239 0.02% $703,377,820 54 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 16, 2026
Filing type
13F-HR
Position type
COM PAR $.01

Voting authority reported

Sole
528,000
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.